Y-mAbs Therapeutics, Inc. - Common Stock (YMAB)
4.9100
-0.0100 (-0.20%)
Y-Mabs Therapeutics Inc. is a biotechnology company focused on discovering and developing innovative antibody therapeutics for the treatment of cancer, particularly in pediatric populations
The company specializes in engineered monoclonal antibodies designed to target specific tumor-associated antigens, leveraging advanced technologies to enhance therapeutic efficacy and safety. Y-Mabs is dedicated to addressing unmet medical needs by advancing its product candidates through clinical trials, with the goal of improving outcomes for patients with various forms of cancer.
Frequently Asked Questions
Is Y-mAbs Therapeutics, Inc. - Common Stock publicly traded?
Yes, Y-mAbs Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Y-mAbs Therapeutics, Inc. - Common Stock trade on?
Y-mAbs Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Y-mAbs Therapeutics, Inc. - Common Stock?
The ticker symbol for Y-mAbs Therapeutics, Inc. - Common Stock is YMAB on the Nasdaq Stock Market
What is the current price of Y-mAbs Therapeutics, Inc. - Common Stock?
The current price of Y-mAbs Therapeutics, Inc. - Common Stock is 4.910
When was Y-mAbs Therapeutics, Inc. - Common Stock last traded?
The last trade of Y-mAbs Therapeutics, Inc. - Common Stock was at 11:37 am EDT on March 21st, 2025
What is the market capitalization of Y-mAbs Therapeutics, Inc. - Common Stock?
The market capitalization of Y-mAbs Therapeutics, Inc. - Common Stock is 219.91M
How many shares of Y-mAbs Therapeutics, Inc. - Common Stock are outstanding?
Y-mAbs Therapeutics, Inc. - Common Stock has 44.79M shares outstanding.